Current challenges and emerging opportunities of chimeric antigen receptor-engineered cell immunotherapy
Abstract Chimeric antigen receptor (CAR) engineered cellular immunotherapy offers the potential for precise targeting and elimination of tumor cells, providing a tailored approach to cancer treatment. CAR-T cells demonstrate significant anti-tumor activity among these therapies. Nonetheless, these t...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2025-07-01
|
| Serija: | Experimental Hematology & Oncology |
| Teme: | |
| Online pristup: | https://doi.org/10.1186/s40164-025-00683-y |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|